During the past decade, Naha-nishi Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Naha-nishi Clinic" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Naha-nishi Clinic" are "Triple Negative Breast Cancer" (2 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Naha-nishi Clinic" in a lesser frequency.

Most popular intervention types in "Naha-nishi Clinic" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (2 trials), "Paclitaxel" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab Placebo" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Naha-nishi Clinic" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Naha-nishi Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Naha-nishi Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Naha-nishi Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".